These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32542771)

  • 1. Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Bongomin F; Asio LG; Olum R; Denning DW
    Mycoses; 2020 Sep; 63(9):921-927. PubMed ID: 32542771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections.
    Olson JA; George A; Constable D; Smith P; Proffitt RT; Adler-Moore JP
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3884-94. PubMed ID: 20606065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
    Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
    Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
    Sehgal IS; Dhooria S; Prasad KT; Muthu V; Aggarwal AN; Chakrabarti A; Agarwal R
    Mycoses; 2021 Sep; 64(9):1053-1061. PubMed ID: 34031920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
    Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
    Keir GJ; Garfield B; Hansell DM; Loebinger MR; Wilson R; Renzoni EA; Wells AU; Maher TM
    Thorax; 2014 Mar; 69(3):287-8. PubMed ID: 24029745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic pulmonary aspergillosis.
    Izumikawa K; Tashiro M; Kohno S
    Ann N Y Acad Sci; 2012 Dec; 1272():40-8. PubMed ID: 23231713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal Therapies for Aspergillus spp.: Present and Future.
    Eschenauer GA
    Semin Respir Crit Care Med; 2024 Feb; 45(1):61-68. PubMed ID: 38151025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
    Evans TJ; Lawal A; Kosmidis C; Denning DW
    Semin Respir Crit Care Med; 2024 Feb; 45(1):88-101. PubMed ID: 38154471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the treatment of chronic pulmonary aspergillosis.
    Armstrong-James D; Kosmidis C; Bromley M
    Curr Opin Infect Dis; 2023 Apr; 36(2):146-151. PubMed ID: 36912585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
    Yamashita C; Takesue Y; Matsumoto K; Ikegame K; Enoki Y; Uchino M; Miyazaki T; Izumikawa K; Takada T; Okinaka K; Ueda T; Miyazaki Y; Mayumi T
    J Infect Chemother; 2020 Jun; 26(6):596-603. PubMed ID: 32171659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
    Tsekoura M; Ioannidou M; Pana ZD; Haidich AB; Antachopoulos C; Iosifidis E; Kolios G; Roilides E
    Pediatr Infect Dis J; 2019 Jan; 38(1):42-49. PubMed ID: 29596219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA; Scott LJ
    Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S; Ohnishi R; Suzuki T; Sano K; Kato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Echinocandin Resistance Due to a Point Mutation in the
    Jiménez-Ortigosa C; Moore C; Denning DW; Perlin DS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis.
    Newton PJ; Harris C; Morris J; Denning DW
    J Infect; 2016 Nov; 73(5):485-495. PubMed ID: 27373381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin.
    Walter J; Sobottka I; Rogiers X; Broering D; Fischer L
    Mycoses; 2011 Jul; 54(4):e220-2. PubMed ID: 20051012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.